Fundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet Neurology, Vol. 23, Núm. 10, pp. 973-1003

  2. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury

    Basic Research in Cardiology, Vol. 119, Núm. 5, pp. 773-794

2023

  1. Prevention of cardiorenal damage: importance of albuminuria

    European heart journal, Vol. 44, Núm. 13, pp. 1112-1123

2022

  1. Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

    Basic Research in Cardiology, Vol. 117, Núm. 1

2020

  1. Physical exercise in cancer: general recommendations might not be enough

    Cancer Causes and Control

  2. Resistant hypertension: New insights and therapeutic perspectives

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 6, Núm. 3, pp. 188-193

  3. The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

    Scientific Reports, Vol. 10, Núm. 1

  4. Uniparental isodisomy as a cause of mitochondrial complex I respiratory chain disorder due to a novel splicing NDUFS4 mutation

    Molecular Genetics and Metabolism, Vol. 131, Núm. 3, pp. 341-348

2018

  1. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

2016

  1. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

2009

  1. Validity of enthesis ultrasound assessment in spondyloarthropathy

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 2, pp. 169-174

2003

  1. Effect of AT 1 receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3